Figure 5.
Coronary sinus creatine kinase MB (ng/mL) evaluation before (T1) and post CPB (T4) for all groups. *p< .05 versus control
Coronary sinus creatine kinase MB (ng/mL) evaluation before (T1) and post CPB (T4) for all groups. *p< .05 versus control